Advertise
NEWSLETTER
IBIO-610 combined with sema...
Cognition Therapeutics wins...
United Therapeutics present...
Function, Google partner to...
Immorta Bio develops AI-des...
IBIO-610 combined with sema...
Cognition Therapeutics wins...
United Therapeutics present...
Function, Google partner to...
Immorta Bio develops AI-des...
AI

Longevity companies to watch in 2021

A year in Longevity: different perspectives

Following the international expansion in South Korea, Vietnam and Indonesia, HautAI skin aging tech now enters the Chinese market.

Skin data innovator announces residency at JLABS @ Shanghai

Following the international expansion in South Korea, Vietnam and Indonesia, HautAI skin aging tech now enters

A year in Longevity: science perspectives

The Hong Kong Regent Pacific group has acquired the Longevity AI and aging clock specialist Deep Longevity.

Regent Pacific completes acquisition of Deep Longevity

BioAge lands $90 million; gears up for clinical trials in 2021

Alon Braun, Neurotech founder

Neurotech2020 – a clear head for neurotech, research and investment

Tina Woods: Prevention is vital for Longevity

Wearable firm switches focus to enterprise

Healthspan wearables and subscription services are hot!

Jinfiniti, NetraMark and Scarlette Lillie will explore the role psilocybin can play for age-related diseases.

Jinfiniti’s Startup Showcase success drives collaboration

Longevity 1.0 – new book seeks to define Longevity

Biofourmis raises $100M to scale digital therapeutics

Deep Longevity acquired by Regent Pacific

Deep Longevity exits stealth to partner with HLI

Tyto Care

At-home diagnostic system sees growth in older users

Biotech AgeX Therapeutics reported financial and commercialises its stem cell lines, but continues to borrow from stakeholder Juvenescence.

G3 and Juvenescence partner on deep learning venture

Real-time tracking of 400+ Longevity biomarkers

AI

AI fast-tracks human longevity extension

Making the Longevity grade: expanded list of 1000 leading names

Longevity Escape Velocity within 10 years?

Senescent cell

AI to quantify senescent cell counts

Singapore-based Gero is the brainchild of Peter Fedichev and are raising $10 million for Longevity drug discovery and indication expansion

Applying theoretical physics to Longevity drug discovery

A year in Longevity: progress perspectives

Loop Digital Connect Healthcare Platform is set to provide provincial and federal healthcare systems in Canada.

Loop Insights launches platform to connect healthcare systems

Study finds that DNA methylation GrimAge clock can predict an individual’s lifespan and healthspan with accuracy.

GrimAge clock – it’s all a matter of time

Deep Longevity publish the first set of psychomarkers of aging developed using deep learning, linking psychological aging mortality risk.

First human AI-powered psychological aging clock published

Epigenetic aging clock DeepMAge has 3-year error margin and could be the most accurate DNA methylation clock to date.

Deep Longevity reveals highly-accurate aging clock

Margaretta Colangelo

Margaretta Colangelo on Longevity2020

Longevity 2020: shaping-up nicely

Deep Longevity continues to build their life-extension ecosystem with a new structured course on Longevity medicine.

Bridging the gap between Longevity science and clinicians

Some good news: announcing Longevity2020

Sentai, a portable smart device for independen living has received a grant from Innovate UK, the UK’s innovation agency.

Start-up Sentai wins UK independent living grant

New learning method could enable AI learning to better mimic the human brain for research into neurodegeneration. 

Brain-inspired AI targets neurodegenerative breakthroughs

Up-skilling clinicians in AI-guided Longevity medicine

There's no place like plasma proteomics when it comes to understanding biological processes and discovering biomarkers says Dr Nir Barzilai

Profiling and understanding plasma proteomes could unlock Longevity

WHO

WHO portal brings aging data together

Start the clock to stop the clock – centralised data will aid Longevity research with Longenesis and Deep Longevity.

Deep Longevity and Longenesis collaborate to clock aging

Tracked.bio develops AI computer vision system to track flies and mice to reduce man-hours and increase data collected in longevity studies.

Big Brother approach to accelerate preclinical studies

A new, highly-detailed cellular and molecular map of the human heart could guide personalised treatments.

Move over, cartography – this is heartography

Japanese pharma Taisho teams with Insilico to discover novel molecules that will tackle aging.

Big pharma enters senolytic drug discovery programme

The latest longevity science, investment, innovation and insight, delivered every morning.

Unlock Longevity Biotech Report for FREE

  • $617BN - Annual global revenue by 2045
  • $30BN+ - Invested in under 2 years
  • 3,036 - Therapeutics individually assessed